ArticleThoracic cancer2022

Impact of the combination of sintilimab and chemotherapy on the tumor and paratumor PD-L1, IDO, TIM-3, FOXP3+ and CD8 expressions in patients with advanced esophageal squamous cell carcinoma.

Shifa Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.